As previously reported on Conduit Street, last month the National Association of Counties’ (NACo) Board of Directors voted to alter the NACo Prescription Discount Card Program, a change that will now provide participating counties with an option to receive a $1 fee for each prescription filled. Below are answers to frequently asked questions about the changes to the program.
Q: If my county has already signed a contract, do we need to sign the new one?
A: If you want to continue participating in the current program without change, the answer is “No.” If, however, you wish to initiate the transaction revenue sharing fee model, you need to sign and submit to NACo, Exhibit B, Rider 1 and your county’s W-9 form. The documents are available on NACo’s website at http://www.naco.org/drugcard.
Q: We would like to have a new, signed agreement for our files. What should we do?
A: If you choose to continue with the current program, sign Exhibit B and return it to NACo. A fully executed copy will be returned to you once it has been signed by all parties. If you choose the transaction revenue sharing fee model, sign both Rider 1 and Exhibit B and your county’s W-9 and return them to NACo. A fully executed copy will be returned to you once it has been signed by all parties.
Q: What does this new contract mean for our residents?
A: The renewed agreement continues the excellent program that has produced 24 percent average prescription savings for your residents. Residents in counties that choose not to participate in the transaction revenue sharing fee model will receive a slightly greater savings percentage.
Q: Can our residents still go to the same pharmacies under this agreement?
A: Yes. This agreement does not affect the size of the pharmacy network. More than 60,000 pharmacies participate in the NACo Prescription Discount Card Network.
Counties that would like to maintain the current program do not need to take any action. However counties that do wish to adopt the transaction revenue sharing fee model must fill out paperwork. For additional information contact Andrew Goldschmidt.
